Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 352

1.

Genetic Variants Associated with Colorectal Adenoma Susceptibility.

Abulí A, Castells A, Bujanda L, Lozano JJ, Bessa X, Hernández C, Álvarez-Urturi C, Pellisé M, Esteban-Jurado C, Hijona E, Burón A, Macià F, Grau J, Guayta R, Castellví-Bel S, Andreu M; PROCOLON research group.

PLoS One. 2016 Apr 14;11(4):e0153084. doi: 10.1371/journal.pone.0153084. eCollection 2016.

2.

Rationale and design of the European Polyp Surveillance (EPoS) trials.

Jover R, Bretthauer M, Dekker E, Holme Ø, Kaminski MF, Løberg M, Zauber AG, Hernán MA, Lansdorp-Vogelaar I, Sunde A, McFadden E, Castells A, Regula J, Quintero E, Pellisé M, Senore C, Kalager M, Dinis-Ribeiro M, Emilsson L, Ransohoff DF, Hoff G, Adami HO.

Endoscopy. 2016 Apr 4. [Epub ahead of print]

PMID:
27042931
3.

Impact of age- and gender-specific cut-off values for the fecal immunochemical test for hemoglobin in colorectal cancer screening.

Alvarez-Urturi C, Andreu M, Hernandez C, Perez-Riquelme F, Carballo F, Ono A, Cruzado J, Cubiella J, Hernandez V, Mao CG, Perez E, Salas D, Andrés M, Bujanda L, Portillo I, Sarasqueta C, Quintero E, Morillas JD, Lanas A, Sostres C, Augé JM, Castells A, Bessa X; COLONPREV study investigators.

Dig Liver Dis. 2016 May;48(5):542-51. doi: 10.1016/j.dld.2016.02.001. Epub 2016 Feb 9.

PMID:
26936343
4.

[Hereditary gastric and pancreatic cancer predisposition syndromes].

Leoz ML, Sánchez A, Carballal S, Ruano L, Ocaña T, Pellisé M, Castells A, Balaguer F, Moreira L.

Gastroenterol Hepatol. 2016 Feb 22. pii: S0210-5705(16)00014-5. doi: 10.1016/j.gastrohep.2015.11.009. [Epub ahead of print] Spanish.

PMID:
26916701
5.

Endoscopist characteristics that influence the quality of colonoscopy.

Jover R, Zapater P, Bujanda L, Hernández V, Cubiella J, Pellisé M, Ponce M, Ono A, Lanas A, Seoane A, Marín-Gabriel JC, Chaparro M, Cacho G, Herreros-de-Tejada A, Fernández-Díez S, Peris A, Nicolás-Pérez D, Murcia O, Castells A, Quintero E; COLONPREV Study Investigators.

Endoscopy. 2016 Mar;48(3):241-7. doi: 10.1055/s-0042-100185. Epub 2016 Feb 4.

PMID:
26845473
6.

Modeling Respiratory Depression Induced by Remifentanil and Propofol during Sedation and Analgesia Using a Continuous Noninvasive Measurement of pCO2.

Hannam JA, Borrat X, Trocóniz IF, Valencia JF, Jensen EW, Pedroso A, Muñoz J, Castellví-Bel S, Castells A, Gambús PL.

J Pharmacol Exp Ther. 2016 Mar;356(3):563-73. doi: 10.1124/jpet.115.226977. Epub 2015 Dec 11.

PMID:
26660440
7.

Recurrent Coding Sequence Variation Explains Only A Small Fraction of the Genetic Architecture of Colorectal Cancer.

Timofeeva MN, Kinnersley B, Farrington SM, Whiffin N, Palles C, Svinti V, Lloyd A, Gorman M, Ooi LY, Hosking F, Barclay E, Zgaga L, Dobbins S, Martin L, Theodoratou E, Broderick P, Tenesa A, Smillie C, Grimes G, Hayward C, Campbell A, Porteous D, Deary IJ, Harris SE, Northwood EL, Barrett JH, Smith G, Wolf R, Forman D, Morreau H, Ruano D, Tops C, Wijnen J, Schrumpf M, Boot A, Vasen HF, Hes FJ, van Wezel T, Franke A, Lieb W, Schafmayer C, Hampe J, Buch S, Propping P, Hemminki K, Försti A, Westers H, Hofstra R, Pinheiro M, Pinto C, Teixeira M, Ruiz-Ponte C, Fernández-Rozadilla C, Carracedo A, Castells A, Castellví-Bel S, Campbell H, Bishop DT, Tomlinson IP, Dunlop MG, Houlston RS.

Sci Rep. 2015 Nov 10;5:16286. doi: 10.1038/srep16286.

8.

[Colorectal cancer screening].

Castells A.

Gastroenterol Hepatol. 2015 Sep;38 Suppl 1:64-70. doi: 10.1016/S0210-5705(15)30021-2. Spanish.

PMID:
26520198
9.

ZEB1 and TCF4 reciprocally modulate their transcriptional activities to regulate Wnt target gene expression.

Sánchez-Tilló E, de Barrios O, Valls E, Darling DS, Castells A, Postigo A.

Oncogene. 2015 Nov 12;34(46):5760-70. doi: 10.1038/onc.2015.352. Epub 2015 Sep 21.

PMID:
26387539
10.

Colorectal cancer risk factors in patients with serrated polyposis syndrome: a large multicentre study.

Carballal S, Rodríguez-Alcalde D, Moreira L, Hernández L, Rodríguez L, Rodríguez-Moranta F, Gonzalo V, Bujanda L, Bessa X, Poves C, Cubiella J, Castro I, González M, Moya E, Oquiñena S, Clofent J, Quintero E, Esteban P, Piñol V, Fernández FJ, Jover R, Cid L, López-Cerón M, Cuatrecasas M, López-Vicente J, Leoz ML, Rivero-Sánchez L, Castells A, Pellisé M, Balaguer F; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association.

Gut. 2015 Aug 11. pii: gutjnl-2015-309647. doi: 10.1136/gutjnl-2015-309647. [Epub ahead of print]

PMID:
26264224
11.

Let-7 Represses Carcinogenesis and a Stem Cell Phenotype in the Intestine via Regulation of Hmga2.

Madison BB, Jeganathan AN, Mizuno R, Winslow MM, Castells A, Cuatrecasas M, Rustgi AK.

PLoS Genet. 2015 Aug 5;11(8):e1005408. doi: 10.1371/journal.pgen.1005408. eCollection 2015 Aug.

12.

Transanal Total Mesorectal Excision for Rectal Cancer: Outcomes after 140 Patients.

Lacy AM, Tasende MM, Delgado S, Fernandez-Hevia M, Jimenez M, De Lacy B, Castells A, Bravo R, Wexner SD, Heald RJ.

J Am Coll Surg. 2015 Aug;221(2):415-23. doi: 10.1016/j.jamcollsurg.2015.03.046. Epub 2015 Mar 30.

PMID:
26206640
13.

Endoscopic surveillance in patients with multiple (10-100) colorectal polyps.

Valentín F, Guarinos C, Juárez M, Rodríguez-Soler M, Serradesanferm A, Rodriguez-Moranta F, Nicolas-Perez D, Bujanda L, Herraiz M, De-Castro L, Fernández-Bañares F, Herreros-de-Tejada A, Martínez F, Aguirre E, Ferrández Á, Díaz-Tasende J, Piñol V, Paya A, Egoavil C, Alenda C, Castells A, Jover R, Cubiella J.

Endoscopy. 2016 Jan;48(1):56-61. doi: 10.1055/s-0034-1392515. Epub 2015 Jul 10.

PMID:
26165738
14.

Choosing the optimal method in programmatic colorectal cancer screening: current evidence and controversies.

Castells A.

Therap Adv Gastroenterol. 2015 Jul;8(4):221-33. doi: 10.1177/1756283X15578610. Review.

15.

Clinical utility of one versus two faecal immunochemical test samples in the detection of advanced colorectal neoplasia in symptomatic patients.

Auge JM, Fraser CG, Rodriguez C, Roset A, Lopez-Ceron M, Grau J, Castells A, Jimenez W.

Clin Chem Lab Med. 2016 Jan;54(1):125-32. doi: 10.1515/cclm-2015-0388.

PMID:
26124057
16.

MiR-320e is a novel prognostic biomarker in colorectal cancer.

Perez-Carbonell L, Sinicrope FA, Alberts SR, Oberg AL, Balaguer F, Castells A, Boland CR, Goel A.

Br J Cancer. 2015 Jun 30;113(1):83-90. doi: 10.1038/bjc.2015.168. Epub 2015 Jun 2.

PMID:
26035698
17.

Efficacy of Adjuvant 5-Fluorouracil Therapy for Patients with EMAST-Positive Stage II/III Colorectal Cancer.

Hamaya Y, Guarinos C, Tseng-Rogenski SS, Iwaizumi M, Das R, Jover R, Castells A, Llor X, Andreu M, Carethers JM.

PLoS One. 2015 May 21;10(5):e0127591. doi: 10.1371/journal.pone.0127591. eCollection 2015.

18.

A case of esophageal adenocarcinoma on long-term rapamycin monotherapy.

Canha C, Ferreira R, Rovira J, Moya-Rull D, Castells A, Diekmann F, Oppenheimer F, Campistol JM, Revuelta I.

Transpl Int. 2015 Oct;28(10):1240-4. doi: 10.1111/tri.12600. Epub 2015 May 19.

PMID:
25939687
19.

Prevalence of MLH1 constitutional epimutations as a cause of Lynch syndrome in unselected versus selected consecutive series of patients with colorectal cancer.

Castillejo A, Hernández-Illán E, Rodriguez-Soler M, Pérez-Carbonell L, Egoavil C, Barberá VM, Castillejo MI, Guarinos C, Martínez-de-Dueñas E, Juan MJ, Sánchez-Heras AB, García-Casado Z, Ruiz-Ponte C, Brea-Fernández A, Juárez M, Bujanda L, Clofent J, Llor X, Andreu M, Castells A, Carracedo A, Alenda C, Payá A, Jover R, Soto JL.

J Med Genet. 2015 Jul;52(7):498-502. doi: 10.1136/jmedgenet-2015-103076. Epub 2015 Apr 23.

PMID:
25908759
20.

Colorectal cancer in a second round after a negative faecal immunochemical test.

Bujanda L, Sarasqueta C, Castells A, Pellisé M, Cubiella J, Gil I, Cosme A, Arana-Arri E, Mar I, Idigoras I, Portillo I; EUSCOLON Study Investigators.

Eur J Gastroenterol Hepatol. 2015 Jul;27(7):813-8. doi: 10.1097/MEG.0000000000000366.

PMID:
25856688
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk